Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer

Arlene O. Siefker-Radtke, Ashish M. Kamat, H. Barton Grossman, Dallas L. Williams, Wei Qiao, Peter F. Thall, Colin P. Dinney, Randall E. Millikan

Research output: Contribution to journal › Article › peer-review

143 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences